BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 23382414)

  • 21. No upregulation of lectin-like oxidized low-density lipoprotein receptor-1 in serum-deprived EA.hy926 endothelial cells under oxLDL exposure, but increase in autophagy.
    Nowicki M; Zabirnyk O; Duerrschmidt N; Borlak J; Spanel-Borowski K
    Eur J Cell Biol; 2007 Oct; 86(10):605-16. PubMed ID: 17643551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.
    Li L; Roumeliotis N; Sawamura T; Renier G
    Circ Res; 2004 Oct; 95(9):877-83. PubMed ID: 15472120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling.
    Ou HC; Song TY; Yeh YC; Huang CY; Yang SF; Chiu TH; Tsai KL; Chen KL; Wu YJ; Tsai CS; Chang LY; Kuo WW; Lee SD
    J Appl Physiol (1985); 2010 Jun; 108(6):1745-56. PubMed ID: 20203069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lipoproteins from pre-eclamptic women on umbilical endothelial cell 6-oxo-prostaglandin f1alpha and endothelin 1 synthesis, and nitric oxide synthase 3 mRNA expression.
    Barden A; Beilin LJ; Both K; Ritchie J; Leedman P; Walters BN; Michael CA
    Clin Sci (Lond); 1999 Dec; 97(6):697-706. PubMed ID: 10585897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human endothelial lecitin-like oxLDL receptor-1 (LOX-1) expression is not associated with impairment of endothelium-dependent vasoreactivity in conduit vessels.
    Wetterau E; Stecher SS; Wolff B; Khouri S; Staudt A; Felix SB; Landsberger M
    J Physiol Pharmacol; 2013 Aug; 64(4):465-72. PubMed ID: 24101392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible change in the behavior of resistance arteries from circulating factor in preeclampsia: an effect specific to myometrial vessels from pregnant women.
    Hayman R; Warren A; Johnson I; Baker P
    Am J Obstet Gynecol; 2001 Feb; 184(3):420-6. PubMed ID: 11228497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1.
    Schreurs MP; Hubel CA; Bernstein IM; Jeyabalan A; Cipolla MJ
    FASEB J; 2013 Mar; 27(3):1254-63. PubMed ID: 23230281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in vascular function by syncytiotrophoblast extracellular vesicles via lectin-like oxidized low-density lipoprotein receptor-1 in mouse uterine arteries.
    Spaans F; Quon A; Rowe SR; Morton JS; Kirschenman R; Sawamura T; Tannetta DS; Sargent IL; Davidge ST
    Clin Sci (Lond); 2018 Nov; 132(21):2369-2381. PubMed ID: 30352791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased circulating oxidised low-density lipoprotein and antibodies to oxidised low-density lipoprotein in preeclampsia.
    Arifin R; Kyi WM; Che Yaakob CA; Yaacob NM
    J Obstet Gynaecol; 2017 Jul; 37(5):580-584. PubMed ID: 28358592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol-lowering drugs inhibit lectin-like oxidized low-density lipoprotein-1 receptor function by membrane raft disruption.
    Matarazzo S; Quitadamo MC; Mango R; Ciccone S; Novelli G; Biocca S
    Mol Pharmacol; 2012 Aug; 82(2):246-54. PubMed ID: 22570368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lectin-like oxidized low-density lipoprotein receptor 1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis.
    Ishikawa M; Ito H; Akiyoshi M; Kume N; Yoshitomi H; Mitsuoka H; Tanida S; Murata K; Shibuya H; Kasahara T; Kakino A; Fujita Y; Sawamura T; Yasuda T; Nakamura T
    Arthritis Rheum; 2012 Apr; 64(4):1024-34. PubMed ID: 22076918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbamylated low-density lipoprotein induces endothelial dysfunction.
    Speer T; Owala FO; Holy EW; Zewinger S; Frenzel FL; Stähli BE; Razavi M; Triem S; Cvija H; Rohrer L; Seiler S; Heine GH; Jankowski V; Jankowski J; Camici GG; Akhmedov A; Fliser D; Lüscher TF; Tanner FC
    Eur Heart J; 2014 Nov; 35(43):3021-32. PubMed ID: 24658767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for increased methylglyoxal in the vasculature of women with preeclampsia: role in upregulation of LOX-1 and arginase.
    Sankaralingam S; Xu H; Jiang Y; Sawamura T; Davidge ST
    Hypertension; 2009 Oct; 54(4):897-904. PubMed ID: 19687346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of matrix metalloproteinases in vascular function: implications for normal pregnancy and pre-eclampsia.
    Merchant SJ; Davidge ST
    BJOG; 2004 Sep; 111(9):931-9. PubMed ID: 15327607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas.
    Wang LJ; Yu YH; Zhang LG; Wang Y; Niu N; Li Q; Guo LM
    Eur J Pharmacol; 2008 Nov; 597(1-3):75-80. PubMed ID: 18796303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmented endothelial uptake of oxidized low-density lipoprotein in response to endothelin-1.
    Morawietz H; Duerrschmidt N; Niemann B; Galle J; Sawamura T; Holtz J
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():9S-12S. PubMed ID: 12193044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low plasma levels of oxidized low density lipoprotein in preeclampsia.
    Raijmakers MT; van Tits BJ; Hak-Lemmers HL; Roes EM; Steegers EA; Peters WH
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1173-7. PubMed ID: 15548151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro plasma-induced endothelial oxidative stress and circulating markers of endothelial dysfunction in preeclampsia: an observational study.
    Pottecher J; Huet O; Degos V; Bonnet MP; Gaussem P; Duranteau J; Ozier Y; Mignon A; Tsatsaris V
    Hypertens Pregnancy; 2009 May; 28(2):212-23. PubMed ID: 19437231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II receptor antagonist reduces subsequent uterine arterial dysfunction in pregnant offspring of protein-restricted rat dams.
    Saito T; Musha Y; Miyakawa M; Itoh S; Ohtsuji M; Hanson MA; Takeda S
    J Obstet Gynaecol Res; 2012 Mar; 38(3):483-9. PubMed ID: 22381101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasoactive effects of 8-epi-prostaglandin F(2alpha)in isolated human placental conduit and resistance blood vessels in vitro.
    Kwek K; Read MA; Khong TY; Bisits AT; Walters WA
    Placenta; 2001 Jul; 22(6):526-33. PubMed ID: 11440540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.